Clinical trial
Management of Metastatic Breast Cancer in Frail Patients
NCT00005614 · H. Lee Moffitt Cancer Center and Research Institute, Other · Withdrawn
Key facts
| NCT number | NCT00005614 |
|---|---|
| Title | Management of Metastatic Breast Cancer in Frail Patients |
| Official title | Management of Metastatic Breast Cancer in Frail Patients |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine hydrochloride |
| Enrollment | 0 |
| Start date | Aug 1, 1999 |
| Primary completion | Jun 1, 2000 |
| Completion | Jun 1, 2000 |
| First posted | Jul 26, 2004 |
| Last update posted | Sep 25, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: